|
PMS2L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.66809996318784E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.9917000000369E-06 |
| Normal-vs-Stage2 |
1.954080E-04 |
| Normal-vs-Stage3 |
5.393800E-02 |
| Normal-vs-Stage4 |
1.943980E-01 |
| Stage1-vs-Stage2 |
1.563150E-01 |
| Stage1-vs-Stage3 |
2.551000E-01 |
| Stage1-vs-Stage4 |
5.170400E-01 |
| Stage2-vs-Stage3 |
1.895580E-02 |
| Stage2-vs-Stage4 |
9.490400E-02 |
| Stage3-vs-Stage4 |
9.296400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63890000459688E-08 |
| Normal-vs-AfricanAmerican |
3.01520000001165E-06 |
| Normal-vs-Asian |
2.600000E-01 |
| Caucasian-vs-AfricanAmerican |
6.312600E-01 |
| Caucasian-vs-Asian |
7.099800E-01 |
| AfricanAmerican-vs-Asian |
5.783200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.5117000418694E-09 |
| Normal-vs-Female |
4.41399999999703E-05 |
| Male-vs-Female |
5.590400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.430840E-04 |
| Normal-vs-Extreme_Weight |
3.54660000000395E-05 |
| Normal-vs-Obese |
4.30129999999807E-05 |
| Normal-vs-Extreme_Obese |
9.494300E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.192200E-01 |
| Normal_Weight-vs-Obese |
8.637800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.906800E-01 |
| Extreme_Weight-vs-Obese |
7.294600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.002400E-01 |
| Obese-vs-Extreme_Obese |
7.667200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.695690E-02 |
| Normal-vs-Age(41-60Yrs) |
4.54229998059219E-09 |
| Normal-vs-Age(61-80Yrs) |
7.13179999944913E-07 |
| Normal-vs-Age(81-100Yrs) |
2.672000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.407800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.242600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.405800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.730800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.074800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.449600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.89084336866108E-13 |
| Normal-VS-Type2 PRCC |
5.616700E-03 |
| Normal-VS-KIRP CIMP |
3.834800E-01 |
| Normal-VS-Unclassified PRCC |
7.280400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.789520E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.75040000000015E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.705910E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.718900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.378400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.756200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.832300E-04 |
| Normal-vs-N1 |
3.093000E-01 |
| Normal-vs-N2 |
5.977400E-01 |
| N0-vs-N1 |
9.378000E-02 |
| N0-vs-N2 |
3.431200E-01 |
| N1-vs-N2 |
8.875000E-01 |
|
|
